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Abstract
Human respiratory syncytial virus (HRSV) and, to a lesser extent, human metapneumovirus (HMPV) and human
parainfluenza virus type 3 (HPIV3), can re-infect symptomatically throughout life without significant antigenic change,
suggestive of incomplete or short-lived immunity. In contrast, re-infection by influenza A virus (IAV) largely depends on
antigenic change, suggestive of more complete immunity. Antigen presentation by dendritic cells (DC) is critical in initiating
the adaptive immune response. Antigen uptake by DC induces maturational changes that include decreased expression of
the chemokine receptors CCR1, CCR2, and CCR5 that maintain DC residence in peripheral tissues, and increased expression
of CCR7 that mediates the migration of antigen-bearing DC to lymphatic tissue. We stimulated human monocyte-derived
DC (MDDC) with virus and found that, in contrast to HPIV3 and IAV, HMPV and HRSV did not efficiently decrease CCR1, 2,
and 5 expression, and did not efficiently increase CCR7 expression. Consistent with the differences in CCR7 mRNA and
protein expression, MDDC stimulated with HRSV or HMPV migrated less efficiently to the CCR7 ligand CCL19 than did IAV-
stimulated MDDC. Using GFP-expressing recombinant virus, we showed that the subpopulation of MDDC that was robustly
infected with HRSV was particularly inefficient in chemokine receptor modulation. HMPV- or HRSV-stimulated MDDC
responded to secondary stimulation with bacterial lipopolysaccharide or with a cocktail of proinflammatory cytokines by
increasing CCR7 and decreasing CCR1, 2 and 5 expression, and by more efficient migration to CCL19, suggesting that HMPV
and HRSV suboptimally stimulate rather than irreversibly inhibit MDDC migration. This also suggests that the low
concentration of proinflammatory cytokines released from HRSV- and HMPV-stimulated MDDC is partly responsible for the
low CCR7-mediated migration. We propose that inefficient migration of HRSV- and HMPV-stimulated DC to lymphatic tissue
contributes to reduced adaptive responses to these viruses.
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Introduction
The paramyxoviruses human respiratory syncytial virus
(HRSV), human metapneumovirus (HMPV) and human parain-
fluenza virus type 3 (HPIV3) are common respiratory pathogens.
HRSV is the most important viral agent of severe pediatric
respiratory tract disease worldwide [1,2], followed by HPIV3 [3,4]
and HMPV [5,6,7,8]. The orthomyxovirus influenza virus type A
(IAV) infects and causes respiratory tract disease in all age groups
[9,10,11].
These human respiratory viruses share a tropism for the
respiratory epithelium and have overlapping spectra of disease,
ranging from rhinitis to bronchiolitis and pneumonia [12,13]. IAV
usually induces long-term immunity following infection, such that
re-infection depends on significant antigenic change [14,15]. In
contrast, HMPV, HRSV and HPIV3 are able to symptomatically
re-infect humans throughout life without significant antigenic
change. This is particularly common with HRSV. Glezen and
colleagues followed children from birth, and found that more than
two-thirds were infected with HRSV during the first year of life,
and almost half of these individuals were re-infected during each of
the next two years [16]. In experimental infections of adults,
typically 50–80% of subjects are re-infected with HRSV, and the
majority has acute illness [17]. In another study, adults were
challenged at intervals of 2–6 months over a period of 26 months
with the same HRSV isolate, with the result that 73% were
infected at least twice and 43% at least three times, and more than
half of these infections were symptomatic [18]. These observations
have been widely interpreted to indicate that HRSV in particular
blunts or skews the immune response, resulting in suboptimal
protection.
Antigen-presenting dendritic cells (DC) are critical for a
functional adaptive immune response. During a lower respiratory
tract infection, the number of DC in the bronchi and lung increases
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circulating monocytes [19,20,21,22]. Migration to non-lymphoid
peripheral tissues such as the lung is mediated by so called
‘‘inflammatory’’ chemokine receptor-ligand pairs, including CCR1-
CCL3/MIP-1a, CCR2-CCL2/MCP-1 or CCR5-CCL5/RANTES.
Exposureof DCto antigen in peripheral tissue initiatesDCmaturation.
During maturation, DC increase the surface expression of co-
stimulatory molecules such as CD38, CD40, CD80 CD86, and
CD83 [23,24]. DC also change their expression of cell surface
chemokine receptors: expression of CCR1, CCR2, and CCR5 is
reduced, reducing responsiveness to inflammatory chemokines,
and expression of CCR7 is increased [25,26]. CCR7 has two
specific ligands, CCL19 and CCL21, which are expressed by
endothelial cells in lymphatic venules, in high endothelial venules
(HEV) in lymph nodes, and in the T cell zone of lymphoid organs
[27,28,29]. CCL19 and CCL21 direct migration of maturing,
CCR7-expressing DC through the afferent lymphatics to the
draining lymph nodes, and control DC positioning within defined
functional lymphoid compartments [25,26,30,31] for efficient
interaction with naı ¨ve and/or antigen-specific memory T
lymphocytes. DC have a key role in determining the magnitude
and quality of the adaptive immune response.
We previously reported that HMPV, HRSV, and HPIV3
induce low-to moderate levels of human monocyte-derived
dendritic cell (MDDC) maturation, cytokine/chemokine expres-
sion, and CD4 T cell proliferation, with the magnitude increasing
slightly in the order HRSV, HMPV, and HPIV3 [32,33]. MDDC
generated in vitro from primary human monocytes by treatment
with IL-4 and GM-CSF represent an appropriate model for lung
DC because monocytes give rise to myeloid DC in the resting lung
[34] and mucosa [35], and are phenotypically and functionally
similar to DC located at sites of inflammation in vivo [36]. In the
present study, we expanded our previous findings by screening
MDDC for expression of genes related to maturation in response
to HMPV, HPIV3, HRSV and, for comparison, IAV. We found
that CCR7 mRNA and protein expression were substantially
increased in response to HPIV3 and IAV, but minimally increased
in response to HMPV and HRSV. These differences detected by
qRT-PCR and flow cytometry were functionally relevant, since
MDDC stimulated with HMPV or HRSV were less efficient in
their migration along a CCR7 concentration gradient than IAV-
and HPIV3 stimulated MDDC. Secondary stimulation of HRSV-
or HMPV-exposed MDDC with the strong DC activator LPS
enhanced CCR7 expression and in vitro migration, suggesting that
suboptimal stimulation, rather than inhibition, is responsible for
this poor-migration phenotype. Finally, we provide evidence that
low CCR7 expression by MDDC in response to HRSV and
HMPV is at least partly due to the low level of expression of pro-
inflammatory cytokines (TNF-a, IL-1a and IL-6).
Materials and Methods
Ethics statement
Elutriated monocytes were obtained from healthy donors at the
Department of Transfusion Medicine of the National Institutes of
Health, under a protocol (99-CC-0168) approved by the IRB of
the Clinical Center, NIH. Written informed consent was obtained
from all donors.
Virus stock preparation
Recombinant (r) HMPV (strain CAN97-83), rHRSV (strain A2)
and rHPIV3 (strain JS) with or without the GFP gene were
described previously [12,37,38]. The present study employed a
genetically ‘‘stabilized’’ version of rHMPV, in which the SH gene
was modified to silently remove tracts of A and T residues that had
been sites of spontaneous mutations during passage in vitro [39].
Human Influenza/A/Udorn/72, a wildtype virus of subtype
H3N2, was used as control.
All viruses were grown on Vero cells and purified by
centrifugation through sucrose step gradients as described
previously [32]. Sucrose purified viruses were pelleted by
centrifugation to remove sucrose. Virus pellets were resuspended
in Advanced RMPI 1640 (Invitrogen, Carlsbad, CA) supplement-
ed with 2 mM L-glutamine (aRPMI), and aliquots were snap
frozen and stored at 280uC until use. Virus titers were determined
by immuno-plaque assay on Vero cells under methylcellulose
overlay (containing trypsin for titration of rHMPV and IAV) as
described previously [37]. In some experiments, UV-inactivated
viruses were included as controls which were prepared using a
Stratalinker UV cross-linker (Agilent, Santa Clara, CA) at 0.5 J/
cm
2. Complete inactivation was monitored by plaque assay (limit
of detection: 5 plaque forming units per mL).
Generation of immature monocyte-derived DC
Elutriated monocytes were obtained from healthy donors at the
Department of Transfusion Medicine of the National Institutes of
Health, under a protocol (99-CC-0168) approved by the IRB of the
ClinicalCenter,NIH.Aspreviouslydescribed[32],monocyteswere
subjected to CD14+ sorting on an Automacs separator (Miltenyi
Biotec, Auburn CA), and cultured in presence of recombinant
human IL-4 (R&D Systems, Minneapolis, MN) and recombinant
human granulocyte-macrophage colony-stimulating factor (GM-
CSF, Bayer Healthcare, Wayne, NJ) for 7 days to generate
immature MDDC. These were confirmed by flow cytometry to be
CD14
2, CD38
2, CD80
low, CD86
low, CD40
low, CD54
low.
MDDC treatments
Immature MDDC were seeded in 12-well plates at 6610
5 cells
per well and were infected with live virus at an MOI of 3 PFU/
Author Summary
The respiratory viruses human respiratory syncytial virus
(HRSV) and, to a lesser extent, human metapneumovirus
virus (HMPV) and human parainfluenza virus (HPIV3), can
re-infect humans throughout life without significant
antigenic change, suggesting that immunity to these
viruses is incomplete. In contrast, re-infection by influenza
A virus (IAV) depends on antigenic change, suggestive of
more complete immunity. Dendritic cells (DC) take up virus
antigen at the site of infection, undergo maturation, and
migrate to the lymphatic tissue to present antigen to T
lymphocytes, orchestrating the immune response. In
response to antigen uptake, DC switch chemokine
receptors on their surface, decreasing expression of
receptors for inflammatory chemokines in the infected
tissue, and increasing expression of CCR7, the sole
chemokine receptor that directs DC to migrate to
lymphatic tissue. By stimulating human DC in vitro,w e
found that, in contrast to HPIV3 and IAV, HMPV and HRSV
did not efficiently induce the switching of these surface
receptors. In cell migration assays, we showed that,
compared with IAV-treated DC, HRSV- or HMPV-treated
DC migrated less efficiently to CCL19, a chemokine that
directs T cell migration to lymphatic tissue. Thus, during
infection with HRSV and HMPV, inefficient migration of DC
to the lymphatics could reduce the adaptive immune
response to these viruses.
HRSV, HMPV Induce Low CCR7 Mediated DC Migration
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stimulated with 1 mg/ml of the superantigen Staphylococcus
enterotoxin B (SEB; Sigma, St Louis, MO) or with 1 mg/ml of
lipopolysaccharide (LPS) from Escherichia Coli O55:B5 (Sigma).
The infectivity of rgHMPV, rgHRSV and rgHPIV3 for MDDC
was similar (approximately 3–5% of GFP+ MDDC at 24 or 48 h
post infection, no significant differences at the p#0.05 confidence
level for any of the data sets of this study). In some experiments,
immature MDDC infected with rgHMPV, rgHRSV, rgHPIV3 at
an input MOI of 3 PFU/cell were further stimulated 4 to 6 h later
with 1 mg/ml of LPS or 150 IU of Interferon (IFN)-b (PBL
Interferon source, Piscataway, NJ) or with a cocktail of pro-
inflammatory cytokines of 6 ng/ml TNF-a, 10 ng/ml IL-6 and
0.36 ng/ml IL-1a (R&D systems). All inoculations or stimulations
were performed in advanced RMPI 1640 (Invitrogen) supple-
mented with 10% heat-inactivated FBS (Hyclone, Logan, UT),
2 mM L-glutamine (Invitrogen), 200 U/ml penicillin, and
200 mg/ml streptomycin (Invitrogen) at 37uCi n5 %C O 2.
Reverse transcription and quantitative PCR
Cell-associated RNA was isolated using the RNeasy mini kit
(Qiagen) as recommended by the manufacturer and treated with
DNAse I to remove residual genomic DNA. Analysis was done in
two ways. The first involved a custom made low-density Taqman
gene array containing 62 genes. Here, 1 mg of isolated RNA was
reverse transcribed using SuperScript II (Invitrogen) in a 50 ml mix
using random primers, and each cDNA mix was loaded onto an
array in triplicate. The second method involved individual RT-
PCR reactions. Here, 600 ng of isolated RNA was reverse
transcribed using superscript II (Invitrogen) in a 25 ml mix using
random primers. The reverse transcription product was diluted
three-fold, and two ml of the diluted cDNA mix were used in each
quantitative TaqMan PCR (Applied Biosystems, CA) for quantifi-
cation of the targets of interest, namely CCR1 (Hs00174298_m1),
CCR5 (Hs00152917_m1) and CCR7 (Hs00171054_m1). qPCR
results were analyzed using the comparative threshold cycle (DDCT)
method, normalized to 18S rRNA and expressed as fold change
over mock.
Flow cytometry analysis of CCR1, 2, 5 and 7 expression
To determine the surface expression level of chemokine
receptors, cells were stained with allophycocyanin (APC)-conjugat-
ed anti-human mAbs [anti-CCR1 (CD191, clone 53504), anti-
CCR2 (CD192, clone 48607), anti-CCR5 (CD195, clone 2D7),
anti-CCR7 (CD197, clone 2H4) (BD Biosciences, San Jose, CA)].
Isotype-matched mAbs were included as controls. Propidium iodide
staining was used to exclude dead cells from further analysis. At
48 h post infection, the median viability of MDDC from six
independent experiments was 85% for HMPV-, 86% for HRSV-,
and 82% for HPIV3-exposed MDDC, reflecting the anti-apoptotic
effects of virus-induced DC maturation [32]. In order to avoid
interference, CCR1, 2, 5 and 7 expression was analyzed
individually. At least 20,000 events were acquired using a
FACSCalibur flow cytometer (BD Biosciences) and analyzed using
FlowJo version 8.8.6 software (Tree Star, Inc., Ashland, OR).
Chemotaxis assay
After 48 h stimulation, migration of the virus-stimulated
MDDC in response to a CCL19 concentration gradient was
evaluated using polycarbonate 5-mm diameter pore size transwells
(Corning, Lowell, MA). 1610
5 live MDDC were seeded in the
upper chamber, and incubated in presence or absence of CCL19
(1 mg/ml, (R&D Systems, Minneapolis, MN) in the lower
chamber. Duplicate wells were used for each condition. After
3 h incubation, MDDC from the lower chamber were harvested,
and the cell density of live cells was determined using a FACS
Calibur flow cytometer (BD Biosciences). For each sample, data
acquisition was performed for 1 min at constant flow using 200 ml
final volume. Forward scatter, side scatter, live/dead staining, and
GFP expression were analyzed using FlowJo version 8.8.6 software
(Tree Star, Inc., Ashland, OR). The average number of MDDC
specifically migrating in response to CCL19 was calculated as
follows: (Average number of stimulated MDDC migrated in the
presence of CCL19) – (Average number of stimulated MDDC
migrated in the absence of CCL19).
Statistical analysis
Data sets were assessed for significance using parametric one-
way repeated measures ANOVA with the Tukey post hoc tests for
normally distributed data sets or the non-parametric Friedman test
with Dunns post hoc test. A log10 transformation was applied to
data sets when necessary to obtain equal standard deviation
among groups, a necessary requirement of both tests. Statistics
were performed using Prism 5 (GraphPad Software, Inc, San
Diego, CA). Data were only considered significant at P,0.05.
Analysis of CCR5 and CCR7 expression: To account for the
smaller data set of the IAV control (n=8 donors, except for IAV,
n=6 donors), data were analyzed using an unbalanced repeated
measures ANOVA (JMP version 8.0.2; SAS, Cary, NC).
Results
Gene expression survey of human MDDC stimulated with
rHMPV, rHRSV, rHPIV3 and IAV
We used RT-qPCR to survey maturation-related gene expres-
sion in MDDCs from 3 donors 24 h after exposure to either the
superantigen SEB or to purified live or UV-inactivated rHRSV,
rHMPV, rHPIV3, or IAV (Fig. S1A and B). In general, all four
live viruses induced the up-regulation of the same array of genes
but differed in the intensity of up-regulation increasing in the order
rHRSV,rHMPV,IAV,rHPIV3. The donors also had substan-
tial responses to UV-inactivated IAV, but weak responses to UV-
inactivated rHMPV, rHRSV or rHPIV3. Donors 1 and 2 were
refractory to stimulation by rHMPV and rHRSV, respectively.
Among the genes surveyed, expression of CCR7 mRNA was
substantially increased in response to IAV and rHPIV3, but not in
response to rHMPV and rHRSV (Fig. S1A). Based on these
preliminary results, we analyzed CCR7 mRNA expression by
qPCR in additional donors (total n=9, Fig. 1), and found that,
while IAV and HPIV3 induced a strong increase of CCR7 mRNA
(median increases of 23-fold and 7.2 fold, respectively), HRSV and
HMPV only induced a 2.2- and 2.5-fold increase compared to
mock treated cells. The effects of HMPV and HRSV on CCR7
expression were significantly smaller compared to HPIV3 and
IAV (Fig. 1). By contrast, expression of CCR1 and CCR5 mRNA
was increased in response to all viruses, but without any statistical
difference between the viruses, except that the CCR5 mRNA
expression was significantly different between rHPIV3 and IAV
(Fig. 1). Because CCR7 has a unique role in DC migration
towards lymph nodes and the subsequent adaptive response [26],
we explored the effect of these viruses on MDDC chemokine
receptor expression and migration.
MDDC treated with rgHMPV or rgHRSV do not efficiently
change cell surface chemokine receptor expression
We next used flow cytometry to measure surface expression of
CCR1, 2, 5, and 7 on MDDC 48 h after exposure to the different
viruses (Fig. 2). We included CCR2 in this analysis since, like
HRSV, HMPV Induce Low CCR7 Mediated DC Migration
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and is down-regulated during DC maturation. LPS was used as
positive control because it strongly activates DC [40,41]. Fig. 2A
shows primary data for a representative donor, and Fig. 2B–C
show the compiled results for six to eight donors. In this and all
subsequent experiments, we used versions of rHMPV, rHRSV,
and rHPIV3 that express GFP from an added gene (rgHMPV,
rgHRSV, and rgHPIV3, respectively).
In mock-treated MDDC, substantial subpopulations of cells
expressed CCR1 (median 91% of total), CCR2 (34%), and CCR5
(75%), and were CCR7-negative or low (Fig. 2A, B, C). High
CCR1/2/5 and low CCR7 values would be typical for immature
DC residing in peripheral tissue. As expected, LPS treatment
induced a significant down-regulation of CCR1 (32%), CCR2
(9%), and CCR5 (24%), and up-regulation of CCR7 (48%
positive cells) (Fig. 2A, B, C). Stimulation of MDDC with
rgHPIV3 or IAV also induced a significant decrease in frequency
of cells expressing the inflammatory chemokine receptors CCR1,
2, and 5 compared to mock-treated cells (Fig. 2B). However, only
IAV significantly decreased all median fluorescence intensities
(MFIs) (Fig. 2C).
In contrast, stimulation with rgHMPV or rgHRSV had only
moderate effects on chemokine receptor surface expression. Cell
surface expression of CCR1 and 2 decreased after stimulation with
rgHRSV and rgHMPV, but the difference compared to mock-
treated MDDC was not significant (Fig. 2B and C), except for the
MFI of CCR1 (Fig. 2C). Stimulation with rgHMPV or rgHRSV
reduced the percentage of CCR5+ MDDC significantly compared
to mock-treated MDDC, but treatment with IAV reduced CCR5
expression significantly more than rgHMPV or rgHRSV treat-
ment (Fig. 2B). CCR5 expression of rgHPIV3 stimulated MDDC
was intermediate between HMPV and HRSV on the one hand,
and IAV on the other hand, with no significant differences to any
of the viruses (Fig. 2C).
The limited down-regulation of CCR1, 2, and 5 in response to
rgHMPV and rgHRSV was coupled with a weak increase of
CCR7 expression occurring on only a small subpopulation of cells
(Fig. 2B, median 7% CCR7
+ cells for for rgHMPV, and 6% for
rgHRSV, with no statistical difference to mock). Stimulation with
rgHPIV3 or IAV was associated with a significantly stronger up-
regulation of CCR7 than mock, rgHMPV or rgHRSV stimula-
tion, resulting in 13% and 37% CCR7+ cells, respectively.
Taken together, these results showed that compared to LPS,
IAV, and rgHPIV3, stimulation with rgHMPV and rgHRSV
induced a smaller down-regulation of surface expression of CCR1,
CCR2, and CCR5, and a smaller up-regulation of CCR7 surface
expression occurring on a smaller fraction of cells.
MDDC treated with HMPV or HRSV migrate poorly to
the CCR7 ligand CCL19. We asked whether the lower level of
CCR7 surface expression by MDDC stimulated with rgHRSV or
rgHMPV affected their migration in response to the CCR7
ligand CCL19. MDDC were stimulated with LPS or the various
live or UV-inactivated viruses and assayed for the ability to
migrate along a CCL19 concentration gradient in a trans-well
system (Fig. 3). As expected, LPS-stimulated MDDC migrated
well, while mock and UV-inactivated virus-stimulated MDDC
migrated poorly towards CCL19. There was a small (but not
statistically significant) increase in migration for UV-IAV
stimulated MDDC (between 302 and 1417 specifically
migrating MDDC), commensurate with the slight increase in
CCR7 mRNA expression in two out of 3 donors after exposure to
UV-inactivated IAV virus (Fig. S1A). Complete UV inactivation
of IAV and the other viruses had been verified by titration. Thus,
the small stimulatory effect of UV-IAV could not be attributed to
partial inactivation of IAV.
Migration of MDDC towards CCL19 was increased for each
of the live viruses. However, MDDC stimulated with live
rgHMPV and rgHRSV migrated less efficiently towards CCL19
than cells stimulated with rgHPIV3 and IAV (medians: 202, 246,
1445, and 2903 specifically migrating MDDC, respectively).
While rgHPIV3- and IAV-stimulated MDDC migrated to
CCL19 in significantly higher numbers than mock-stimulated
MDDC, migration of rgHMPV- and rgHRSV-stimulated
MDDC was not significantly different from that of mock-
stimulated MDDC. Migration of IAV-stimulated MDDC was
significantly greater than that of rgHRSV- and rgHMPV-
stimulated MDDC (p,0.01; ANOVA/Tukey post hoc analysis
comparing mock-stimulated MDDC with those stimulated with
Figure 1. CCR1, 5 and 7 gene expression of MDDC stimulated with rHMPV, rHRSV, rHPIV3, or IAV. Immature MDDC (n=9 donors) were
infected with rHMPV, rHRSV, rHPIV3, or influenza/A/Udorn (IAV). Twenty-four h post infection, total cellular RNA was prepared and reverse-transcribed
using random primers, and the cDNA analyzed in triplicate by qPCR using TaqMan PCR assays. qPCR results were analyzed using the comparative
threshold cycle (DDCT) method, normalized to 18S rRNA. The results are expressed as fold-increase over mock. Statistical differences are indicated by
asterisks (* P#0.05, ** P#0.01, *** P#0.001, Materials and Methods).
doi:10.1371/journal.ppat.1002105.g001
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PLoS Pathogens | www.plospathogens.org 4 June 2011 | Volume 7 | Issue 6 | e1002105Figure 2. Cell surface expression of the chemokine receptors CCR1, 2, 5 and 7. Immature MDDC were stimulated with LPS or infected with
rgHMPV, rgHRSV, rgHPIV3, or influenza/A/Udorn (IAV) at an MOI of 3 PFU/cell. 48 h post-infection, the surface expression levels of CCR1, 2, 5 and 7
were assessed by flow cytometry. (A) Surface expression of CCR1, 2, 5, and 7 from a representative donor. The MFI (top right corner) and % positive
(bottom right) of each cell population are indicated for each histogram, with red indicating the treated population and blue indicating the mock-
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regulation of CCR7 mRNA and surface protein expression in
response to rgHMPV and rgHRSV compared to IAV and LPS
was associated with less efficient migration in response to
CCL19.
Comparison of chemokine receptor expression on the
GFP-positive versus GFP-negative subpopulations of
virus-stimulated MDDC
We used flow cytometry to compare chemokine receptor surface
expression on virus-exposed cells that were GFP-positive versus
GFP-negative (Fig. 4). We previously showed that, following
infection with rgHMPV, rgHRSV, or rgHPIV3 at an MOI of 3,
approximately 3–5 % of MDDC were GFP+ at 24 or 48 h post-
infection [32]. This was indicative of robust viral gene expression,
which was confirmed by RT-qPCR. In the GFP– population, we
detected a low level of viral gene expression, suggestive of abortive
virus replication [32]. Thus, comparing host gene expression in
GFP+ and GFP– cells provides an indication of the effects of a
robust versus abortive infection. Fig. 4A shows primary data for
GFP expression and CCR7 surface expression for a single donor,
and Fig. 4B summarizes data for the expression of CCR1, 2, 5,
and 7 for six donors.
After treatment of MDDC with rgHMPV or rgHPIV3, the
extent of down-regulation of CCR1, 2, and 5 was similar between
the GFP+ and GFP2 MDDC (Fig. 4). In contrast, after rgHRSV
treatment, these receptors were decreased only in the GFP2 cells;
indeed, in the GFP+ cells, CCR2 and CCR5 expression was
slightly increased compared to mock treated cells. Thus, robust
rgHRSV gene expression did not induce the down-regulation of
the inflammatory chemokine receptors CCR1, 2, and 5 that
normally occurs as part of DC maturation.
CCR7 was expressed at higher levels in the GFP+ cells than in
the GFP2 cells after treatment with rgHMPV or rgHPIV3,
indicating that robust infection by these viruses stimulated rather
than inhibited expression (Fig. 4A and B). In contrast, CCR7
expression was not increased in either the GFP+ or the GFP2
subpopulations of cells treated with rgHRSV.
The weak CCR7-driven migration of MDDC treated with
rgHMPV and rgHRSV can be increased by secondary
stimulation with pro-inflammatory cytokines or LPS
One possible explanation for the weak chemokine receptor
modulation and migration by rgHMPV- and rgHRSV-treated
MDDC was direct virus-mediated inhibition. Alternatively, it was
possible that these viruses were insufficiently stimulatory, perhaps
due to the low production of cytokines by virus-treated MDDC as
described in our previous study [32]. We therefore investigated
whether exposure of virus-stimulated MDDC to secondary
stimulation with LPS or to higher concentrations of cytokines
would result in more efficient chemokine receptor modulation and
migration. We tested possible cytokine and IFN candidates based
on the gene expression analysis described above (Fig. S1) and
previously published data by ourselves and others
[32,42,43,44,45,46]. The individual additions of IFN-b, IL-28,
IL-29, TNF-a, IL-1a, IL-6 and prostaglandin E2 to virus-treated
MDDC had little or no effect on CCR7 mRNA levels or on the
ability of MDDC to migrate to a CCL19 concentration gradient
(data not shown). These preliminary results confirmed previously
published data showing that CCR7 is not an IFN-regulated gene
Figure 3. MDDC stimulated with IAV migrate more efficiently
to a CCL19 concentration gradient than HMPV- or HRSV-
stimulated MDDC. Immature MDDC were stimulated with LPS or
infected with rgHMPV, rgHRSV, rgHPIV3, IAV, or with their UV-
counterparts and, 48 h following stimulation, were assessed for the
ability to migrate in vitro to a CCL19 concentration gradient. This was
done using transwell cultures containing a polycarbonate filter with a
pore diameter of 5 mm. 1610
5 live MDDC were seeded in the upper
chamber and incubated in presence or absence of CCL19 in the lower
chamber. After 3 h, MDDC from the lower chamber were harvested, and
the cell density was determined by flow cytometry. Data were
expressed as the average number of MDDC migrating specifically to a
CCL19 concentration gradient, calculated as follows: (Average number
of stimulated MDDC migrating in the presence of CCL19) – (Average
number of stimulated MDDC migrating in the absence of CCL19). The
median number of MDDC migrating in absence of CCL19 for the seven
analyzed donors was 207, and thus the background was low. The box
plots show the median (horizontal line), flanked by the 2
nd and 3
rd
quartile. The outer bars show the range of values. Each donor is
represented by an individual symbol. n=7 donors except for the UV-
inactivated viruses, where n=3 donors. Statistical differences are
indicated by asterisks (* P#0.05, ** P#0.01, *** P#0.001, Materials
and Methods).
doi:10.1371/journal.ppat.1002105.g003
treated control. Note that values of MFI are not given in the case of CCR7 because only a small percentage of treated MDDC expressed this molecule
at the cell surface. (B, C) Summary of data expressed as % positive cells (B) and as MFI (C). MFI is not shown for CCR7, as explained for (A). CCR1, 2:
n=6 donors; CCR5, 7: n=8 donors, except n=6 donors for IAV. The box plots show the median (horizontal line), flanked by the 2
nd and 3
rd quartile.
The outer bars show the range of values. Statistical differences are indicated by asterisks (* P#0.05, ** P#0.01, *** P#0.001, Materials and Methods).
CCR5 and 7 expression: To account for the smaller data set of the IAV control (n=8 donors, except for IAV, n=6 donors), data were analyzed using an
unbalanced repeated measures ANOVA (JMP 8.0.2; SAS, Cary, NC). Treatments sharing the same lower case letters do not differ significantly at the
p#0.05 confidence level, see Materials and Methods.
doi:10.1371/journal.ppat.1002105.g002
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of CCR7 by rgHMPV and rgHRSV is unlikely to be the result of a
more stringent IFN antagonism by these viruses.
We next tested the effect of a cocktail of pro-inflammatory
cytokines containing TNF-a, IL-1a and IL-6 on chemokine
receptor expression, with each cytokine in concentrations similar
to those induced by LPS under our experimental conditions [32].
MDDC (n=4 donors) were treated with rgHMPV or rgHRSV,
and, 4–6 h later, received a secondary stimulation with the
cocktail of pro-inflammatory cytokines or with LPS. The
expression levels of CCR7 mRNA were quantified 24 h post-
infection (Fig. 5A). The secondary treatment with LPS induced a
significant (p,0.05) increase of CCR7 mRNA expression in
rgHMPV- and rgHRSV-stimulated MDDC. Thus, the relatively
low level of expression of CCR7 in MDDC exposed to rgHMPV
or rgHRSV was not due to an irreversible block. Following
treatment with the cocktail of pro-inflammatory cytokines, there
was an increase of CCR7 mRNA in mock-, rgHMPV- or
rgHRSV-stimulated MDDC, although there was substantial
individual variation and this increase did not reach statistical
significance. This suggests that the low level of expression of
CCR7 mRNA in MDDC stimulated with rgHMPV or rgHRSV
might be partly a consequence of the low levels of TNF-a, IL-1a
and IL-6 produced after exposure to rgHMPV or rgHRSV.
Figure 4. Chemokine receptor surface expression on GFP-positive versus GFP-negative MDDC following inoculation with rgHMPV,
rgHRSV and rgHPIV3. 48 h after stimulation with LPS or infection with the indicated viruses, GFP+ and GFP2 cells were analyzed by flow
cytometry for cell surface expression of the indicated chemokine receptors. (A) Scatter plots of GFP expression and CCR7 surface staining from a
typical donor and (B) summary of the data from n=6 donors. (+) GFP+ population, (2) GFP2 population. The box plots show the median (horizontal
line), flanked by the 2
nd and 3
rd quartile. The outers bars show the range of values. Statistical differences are indicated by asterisks (* P#0.05,
** P#0.01, *** P#0.001, Materials and Methods). Note that the statistical differences between the GFP+ cells from a given virus and the GFP2 cells
from a different virus are not shown.
doi:10.1371/journal.ppat.1002105.g004
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PLoS Pathogens | www.plospathogens.org 8 June 2011 | Volume 7 | Issue 6 | e1002105To measure cell surface protein expression, MDDC that were
treated with rgHMPV or rgHRSV and given a secondary
stimulation with the pro-inflammatory cytokine cocktail or LPS,
as described above, were analyzed by flow cytometry at 48 h post-
infection. Consistent with the results at the mRNA level,
stimulation with the proinflammatory cytokine cocktail induced
a partial decrease in CCR1, 2 and 5 as well as a partial increase in
CCR7 surface expression (Fig. 5B and C; B: 1 representative
donor, and C: n=6 donors). Secondary stimulation with LPS had
stronger effects in all cases.
We also evaluated replicate samples to investigate if the profile
of CCR7 mRNA and protein expression correlated with the ability
of MDDC to migrate to a CCL19 concentration gradient,
measured 48 h post-infection (Fig. 5D, n=5 donors). Indeed,
secondary stimulation with LPS induced a strong and significant
(p#0.05) increase of migration of rgHMPV- and rgHRSV-
stimulated MDDC as compared to virus-treated cells given a
mock secondary treatment. Following secondary stimulation of
virus-treated cells with the cocktail of pro-inflammatory cytokines,
there was an increase in migration of mock-, rgHMPV- and
rgHRSV-stimulated MDDC, although this did not reach statistical
significance, and did not reach the level of increase induced by
LPS. Taken together, these results suggest that the low
concentration of TNF-a, IL-1a and IL-6 induced by rgHMPV
and rgHRSV is partly responsible for the low CCR7 mediated
migration.
Chemokine receptor expression in GFP-positive versus
GFP-negative virus-stimulated MDDC following
secondary stimulation with a cocktail of pro-
inflammatory cytokines or LPS
We next investigated possible effects of robust viral infection
(indicated by intracellular GFP expression) on chemokine receptor
expression following treatment with the pro-inflammatory cyto-
kine cocktail or LPS. This was done by infecting MDDC (n=6
donors) with rgHMPV, rgHRSV, or rgHPIV3, subjecting them to
a secondary stimulation with the pro-inflammatory cytokine
cocktail or LPS at 4 h post-infection, and using flow cytometry
to analyze the cell surface expression of CCR1, 2, 5, and 7 in the
GFP-positive versus the GFP-negative populations at 48 h post-
infection (Fig. 6).
Secondary stimulation of rgHMPV-, rgHRSV-, or rgHPIV3-
stimulated MDDC with LPS decreased cell surface expression of
CCR1, 2, and 5 on both GFP+ and GFP2 cells. Secondary
stimulation with the cocktail of pro-inflammatory cytokines also
induced a decrease in surface expression of CCR1, 2, and 5.
However, the magnitude of the effect usually was less than that
observed with LPS.
Secondary stimulation of rgHMPV-, rHRSV-, or rgHPIV3-
exposed MDDC with LPS induced an equally strong increase of
CCR7 surface expression on GFP+ and GFP2 cells, compared
to cells that did not receive the secondary treatment (Fig. 6).
Secondary stimulation of virus-infected cells with the pro-
inflammatory cocktail also induced increases in CCR7 expres-
sion on both GFP2 and GFP+ cells, although only in the case of
rgHRSV GFP2+ and GFP2 cells and rgHPIV3 GFP2 cells
was this difference statistically significant compared to cells
receiving a mock secondary treatment. This provided further
evidence that the poor expression of CCR7 in MDDC exposed
to rgHRSV or rgHMPV could be overcome by secondary
stimulation with LPS, and substantially overcome by secondary
stimulation with the cocktail of pro-inflammatory cytokines.
These increases were observed both in GFP+ and GFP2 cells,
indicating that robust viral infection did not irreversibly block
CCR7 expression.
Discussion
Compared to HPIV3 or IAV, stimulation of human MDDC
with HRSV or HMPV in vitro resulted in inefficient maturational
changes in chemokine receptor usage – namely down-regulation of
CCR1, CCR2, and CCR5 and up-regulation of CCR7 – that are
necessary for DC migration in vivo following antigen uptake.
MDDC stimulated with HRSV or HMPV did not migrate
efficiently towards a CCL19 gradient in an in vitro assay, compared
to HPIV3 or IAV, confirming that the poor surface expression of
CCR7 had functional consequences. The weak chemokine
receptor modulation and migration by MDDC exposed to HMPV
and HRSV, viruses that are thought to induce incomplete
immunity, was particularly evident compared to MDDC exposed
to IAV, a virus that induces effective immunity.
In vivo, maturing, antigen-bearing DC migrate from peripheral
tissue to secondary lymphatic tissue and localize in defined
lymphoid compartments, where they present antigens to CD4+
and CD8+ T lymphocytes, initiating and polarizing the T cell
response [26,50]. DC migration to and positioning within
lymphatic tissue are critical towards mounting an effective
adaptive immune response [50]. While there are multiple
chemokine receptors that direct immature DCs towards peripheral
sites, CCR7 is the only receptor that mediates migration toward
and positioning within lymphatic compartments for interaction
with T lymphocytes [30,51,52,53]. Thus, differential effects of
pathogens on CCR7 expression in particular could be functionally
relevant for differences in the immune response to these
pathogens. Accordingly, the reduced migration observed in our
in vitro assay for HMPV- and HRSV-treated MDDC following
stimulation with HRSV and HMPV suggests that, during an
HMPV or HRSV infection in vivo, maturing DC migrate with
reduced efficiency from the infected mucosa towards secondary
lymphatic tissues. This might lead to reduced adaptive immune
responses that could explain the greater ability of HMPV and
HRSV to reinfect humans throughout life without need for
significant antigenic change.
Figure 5. A cocktail of pro-inflammatory cytokines TNF-a/IL-1a/IL-6 partly restores the CCR7-driven migration of rgHMPV- or
rgHRSV-stimulated MDDC. MDDC were infected with rgHMPV or rgHRSV and, 4–6 h post-infection, replica MDDC cultures were stimulated with a
cocktail of the pro-inflammatory cytokines TNF-a/IL-1a/IL-6 or with LPS. (A) CCR7 mRNA levels in cells harvested at 24 h post-infection were
quantified by RT-qPCR using the DDCT method and expressed as fold change over mock. Each symbol represents an individual donor; n=4 donors.
(B, C) Cell surface expression of the chemokine receptors CCR1, CCR2, CCR5 and CCR7 in cells harvested 48 h post-infection were quantified by flow
cytometry. Primary data from a representative donor (B) and summary of data from n=6 donors are shown (C). The box plots show the median
(horizontal line), flanked by the 2
nd and 3
rd quartile. The outer bars show the range of values. (D) MDDC migration to a CCL19 gradient, measured
using the assay in Fig. 3, for cells harvested 48 h post-infection. The box plots show the median (horizontal line), flanked by the 2
nd and 3
rd quartile.
The outer bars show the range of values. n=5 donors. Statistically significant differences induced by cytokine or LPS treatment, and differences of
any sample compared to untreated mock-infected cells, are indicated by asterisks (* P#0.05, *** P#0.001, see materials and methods for statistical
analysis).
doi:10.1371/journal.ppat.1002105.g005
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PLoS Pathogens | www.plospathogens.org 9 June 2011 | Volume 7 | Issue 6 | e1002105Figure 6. Surface expression of chemokine receptors on GFP-positive and GFP-negative MDDC after inoculation with rgHMPV,
rgHRSV and rgHPIV3 and secondary stimulation with the pro-inflammatory cytokines TNF-a/IL-1a/IL-6 or with LPS. 4–6 h after
infection of immature MDDC with rgHMPV or rgHRSV, cells were stimulated with a cocktail of the pro-inflammatory cytokines TNF-a/IL-1a/IL-6 or LPS.
48 h after the initial infection, GFP-positive and GFP-negative cells were analyzed by flow cytometry for cell surface expression of the indicated
chemokine receptors. n=6 donors. (+) GFP+ population, (2) GFP2 population. The box plots show the median (horizontal line), flanked by the 2
nd
and 3
rd quartile. The outers bars show the range of values. Statistical differences between relevant groups, i.e. with and without cytokine treatment,
are indicated by asterisks (* p#0.05, **p#0.01, *** P#0.001, see materials and methods).
doi:10.1371/journal.ppat.1002105.g006
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multiple donors. While the use of cells from an outbred population
provides data with substantial individualistic differences and
reduced statistical significance compared to convenient, uniform
hosts like inbred mice, it is important to note that the natural host
of the viruses in the present study is the human and not the mouse.
Direct in vivo studies of virus-specific effects on DC migration
during respiratory infections of humans are difficult, especially in
children. Gill et al [54] noted that DC persisted in the lungs of
children hospitalized for HRSV infection for as long as 8 weeks
following the resolution of infection [55]. Resorting to data from
mice, sustained increases in pulmonary DC have also been
observed following HRSV infection [56]. Lucken et al [57] tracked
the migration of mouse DC following HRSV infection and showed
that the increase in DC numbers in the mouse mediastinal lymph
node was slower compared to IAV or Sendai virus infection
[58,59,60]. These observations would be consistent with inefficient
migration from the lung to lymphoid tissue. Our in vitro studies
now provide a mechanism for these previous in vivo observations.
In addition, we provided data that MDDC maturation also was
reduced with HMPV compared to HPIV3 and IAV.
We previously provided data indicating that the level of MDDC
maturation in response to exposure to HMPV and HRSV is lower
compared to HPIV3 [32] and IAV (not shown). In vivo, the
combination of these two factors, namely reduced overall
maturation and inefficient CCR7-CCL19 driven migration, might
result in additive net effects that could affect both the magnitude
and the quality of the adaptive immune response. Compared to
infection with IAV, HRSV and HMPV infections may yield lower
overall numbers of virus-stimulated mature DC in the afferent
lymphatics. Reduced expression of co-stimulatory surface mole-
cules and reduced cytokine expression could affect the quality of
the response as well as its magnitude. In addition, the inefficient
migration of maturing DCs may also play a role in viral
pathogenesis: specifically, the sustained presence of mature DC
in the mouse lung has been suggested to contribute to airway
inflammation [56].
Another paramyxovirus, measles virus (MeV), was recently
shown to inhibit CCR7-driven DC migration. Interference with
DC maturation and function is considered to be central to MeV-
induced immunosuppression. Compared to LPS, MeV infection
failed to promote the switch from CCR5 to CCR7 expression, and
MeV-matured DC exhibited chemotactic responses to CCL3
rather than to CCL19 [61]. Inhibition of CCR7-driven migration
was also described for vaccinia virus and for herpes simplex virus
type 1 [45,62,63]. However, the effects of reduced DC maturation
and migration on long-term protection might be particularly
significant for respiratory viruses such as HMPV and HRSV. Both
of these viruses are restricted in tropism to the superficial cell layer
of the respiratory tract, and protection against re-infection has
reduced effectiveness (compared to viremic viruses, for example)
due to the short-lived nature of local IgA antibodies, the
inefficiency with which serum antibodies access the respiratory
lumen, and the down-regulation of virus-specific CD8+ T cell
functionality in the respiratory tract [64]. Thus, even modest
decreases in the magnitude of the adaptive response could result in
decreases in viral clearance and protection against re-infection.
We used recombinant GFP-expressing viruses to distinguish
between effects in robustly infected (GFP-positive) and uninfected/
abortively-infected (GFP-negative cells) MDDC. This revealed
additional differences between the viruses. For MDDC infected
with HMPV or HPIV3, the GFP-positive population expressed
significantly more surface CCR7 than the GFP-negative popula-
tion. In contrast, for MDDC infected with HRSV, the GFP-
positive subpopulation resembled the GFP-negative population in
having very low CCR7 surface expression. Thus, whereas robust
infection with HMPV and HPIV3 stimulated expression of CCR7,
robust infection with HRSV did not. Furthermore, GFP-positive
cells infected with HRSV showed no down-regulation of CCR1, 2,
and 5 surface expression. Thus, compared to HMPV or HPIV3,
even the subpopulation of DC that is robustly infected with HRSV
and contains abundant intracellular antigen would not be
mobilized for migration. This would impede the delivery of
HRSV antigen from the periphery to lymphoid tissue. Further-
more, DC that are robustly infected with a virus can readily
process newly synthesized viral antigens for display on MHC class
I molecules and presentation to CD8+ T cells. Reduced migration
of DC that are robustly infected with HRSV to lymphoid tissue
would reduce this activity. This would make activation of CD8+ T
cells more dependent on cross-presentation by non-infected DC,
and could reduce the efficiency of CD8+ T cell activation during
HRSV infection, reducing viral clearance and the disease-sparing
regulatory effects of HRSV-specific CD8+ T cells [65].
Secondary stimulation of HRSV- or HMPV-stimulated MDDC
with LPS, a strong DC activator, resulted in up-regulation of
CCR7 expression on both GFP-negative and GFP-positive cells
and increased in vitro migration. In contrast, with vaccinia virus or
human cytomegalovirus, a secondary stimulation of the infected
DC with LPS failed to up-regulate the CCR7 chemokine receptor
[45,62]. LPS is a strong NFk-B and AP-1 dependent DC activator
[66,67]. Secondary stimulation of HRSV- and HMPV-infected
MDDC with the NFk-B/AP-1-dependent pro-inflammatory
cytokines TNF-a, IL-1a and IL-6, at concentrations comparable
to those induced by LPS treatment, up-regulated CCR7
expression and was pro-migratory. This suggests that, in contrast
to MeV, vaccinia virus, or herpes simplex virus, suboptimal
stimulation, rather than inhibition, is responsible for the poor-
migration phenotype of pneumovirus-exposed MDDC.
In summary, compared to HPIV3 and, in particular, IAV, the
pneumoviruses HMPV and HRSV were inefficient in inducing the
maturation-related changes in cell surface chemokine receptor
expression in MDDC that are necessary in vivo to re-direct DC
from the periphery to lymphoid tissue. Consistent with this, both
HRSV and HMPV were poor inducers of MDDC maturation and
migration in vitro. These effects could be contributing factors in the
incomplete nature of protection induced by HRSV infection in
humans.
Supporting Information
Table S1 Genes analyzed by TaqMan Gene-Expression
Assay. A low-density Taqman array representing 62 human
genes was used for analysis of gene expression of MDDC
stimulated with rHMPV, rHRSV, rHPIV3, or IAV; genes and
Taqman assay numbers are listed in Table S1.
(DOC)
Figure S1 Gene expression of MDDC stimulated with
rHMPV, rHRSV, rHPIV3, or IAV. Immature MDDC (n=3
donors, numbered 1–3) were stimulated with SEB or infected with
live or UV-inactivated rHMPV, rHRSV, rHPIV3, or influenza/
A/Udorn (IAV). Twenty-four h post infection, total cellular RNA
was prepared and reverse-transcribed using random primers, and
the cDNA analyzed in triplicate by qPCR using a low-density
Taqman array representing 62 human genes (see Table S1). The
genes were grouped based on biological function: i) type I and III
IFNs (n=5), ii) transcription factors (n=10); iii) pro-inflammatory
cytokines (n=6), (iv) Th1 cytokines (n=5), (v) Th2 cytokines
(n=3), (vi) Th17/Tr-1 cytokines (n=5), (vii) pattern recognition
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markers (n=8), (ix) major histocompatibility (MHC) molecules
(n=6), and (x) chemokine receptors (n=5). qPCR results were
analyzed using the comparative threshold cycle (DDCT) method,
normalized to 18S rRNA. (A, B) The results are (A) expressed as
log2 fold change over mock and presented as a heat map (scales
shown to the left of each panel) with each group as a separate
hierarchical cluster of log2 ratios (GENESIS program, release
1.7.2, http://genome.tugraz.at [65]), or (B) as fold-increase over
mock for individual genes. Note that the rHMPV, rHRSV, and
rHPIV3 viruses used in this experiment did not express GFP,
whereas all subsequent experiments used GFP-expressing versions.
Among the responsive donors, one notable difference among the
viruses was the low type I/III IFN response to rHRSV: very low
levels of IFN-a1 and IFN-b were induced, and there was no
induction of IL-28A and IFN-a2. All four viruses induced the
expression of transcription factors involved in orchestrating DC
maturation, and innate immune response genes (IRF-7, IRF-1,
and STAT-1). The transcription factors NFk-B, STAT-3, and
JAK-1 were also increased, albeit at a lower level, and with
substantial donor-to-donor variability. Several pro-inflammatory
chemokine genes, namely CCL8, CCL5, CXCL9, and CXCL10,
were strongly up-regulated by rHMPV, rHPIV3, and IAV. For
rHRSV, the non-responsive donor 2 and also donor 3 showed a
limited response for these cytokines, which may be due to the low
IFN induction by rHRSV. The Th1 associated genes IFN-a,
CXCL9, CXCL10, IL-12A, and IL-18 were strongly up-regulated
in response to all viruses, but the Th2 associated genes IL-4,
CCL22, and CCL17 were not. All of the viruses induced IL-27A
and, to some extent, TGF-b, IL-6, and IL1-b, suggesting that these
MDDC might also be able to induce to some extent a regulatory T
cell (Treg) response. However, IL-23 expression was variable
between donors and appeared increased in donor 2, but decreased
in donor 3, with little difference between rHPMV, rHRSV and
rHPIV3, suggesting a variable Th-17 response. IL-23 was not
induced in any donor in response to IAV. The viruses were similar
with respect to induction of pattern recognition receptors and
adapters. In particular, we detected a strong up-regulation of RIG-
I and Mda5, as well as up-regulation of genes of the TLR
pathways (TLR3 and its adaptor TRIF, TLR7 and TLR8 and
their adaptor MyD88). However, rHPIV3 and IAV induced
down-regulation (3- to 100-fold) of CD14, which is associated with
TLR-4. All of the viruses also induced the up-regulation of typical
cell surface maturation markers including CD38, CD40, CD80,
CD86, MHC-class I, PDL-1 and PDL-2, although the response
tended to be reduced with rHRSV.
(TIF)
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